Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose rabies pre-exposure priming and anamnestic response study
2017-000089-31Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2017
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Rabies vaccine in rabies (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Rate of increase of geometric mean concentration of RVNA between day 0 and day 7 after simulated PEP. Started Jul 2017; status: completed.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2017-000089-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000089-31.